<DOC>
	<DOCNO>NCT02157415</DOCNO>
	<brief_summary>It first clinical study aim assess safety tolerability UT-P routine rinse bacterial decolonization solution device urinary catheter . The study conduct hospitalized adult patient urethral suprapubic catheter place longer two consecutive week able provide write consent . This open-label prospective observational cohort study . No comparative control group plan prevent infection solution commercially available time .</brief_summary>
	<brief_title>Prospective Cohort Study Tolerability &amp; Safety Uro-Tainer® Polihexanide 0.02 %</brief_title>
	<detailed_description>The objective study assess tolerability safety Uro-Tainer® Polihexadine 0.02 % intend routine rinsing bacterial decolonization urinary catheter long-term catheterized patient . After instillation patient assess vital sign , skin reaction symptom suggest intolerance sensitivity and/or allergic reaction . In addition , pain assess first 5 patient patient sustain pain sensation bladder . Catheters rinse gravity feed 100ml solution UT-P 0.02 % day maximum 5 instillation . A minimum interval 24 hour must guarantee enrolment first 5 patient first irrigation investigational product .</detailed_description>
	<criteria>Patients sustain pain sensation bladder ( first five patient ) . Patients stay inpatient longterm ( &gt; 2 week ) urethral suprapubic catheter . Age &gt; 18 year Ability read , write speak German French Women child bear potential must test negative standard urine pregnancy test two week prior start study must agree practice appropriate contraceptive method end study ( e.g . oral contraceptive , IUD , intramuscular contraceptive , abstinence ) . Provision voluntary consent participate study , follow full explanation nature purpose study , sign informed consent approve cantonal Ethics Committee ( IEC ) prior evaluation Symptomatic UTI Hematuria Fever ( tympanic temperature &gt; 38.5°C ) Surgical intervention genitourinary tract last 6 month Patients receive concurrent catheter irrigation Known allergy sensitivity ingredient UroTainer® Polihexanide 0.02 % Known allergy sensitivity chlorhexidine Pregnancy Lactation Simultaneous participation another interventional trial Administration catheter irrigation 1 week prior study Administration follow medication 4 week prior study entry , unless use stable regimen : antibiotic , antipyretic , antihistamine , medication susceptible cause autonomic response mask allergic reaction . For first five patient : impaired pain sensation bladder first five patient : Administration antipyretic analgesic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>